21 results
424B5
ORIC
ORIC Pharmaceuticals Inc
21 Dec 22
Prospectus supplement for primary offering
5:23pm
and restated bylaws provide that stockholders seeking to nominate candidates for election as directors at an annual or special meeting of stockholders … called annual or special meeting of stockholders and may not be effected by written consent.
Amending our certificate of incorporation and bylaws
Our
POS AM
ORIC
ORIC Pharmaceuticals Inc
22 Mar 22
Prospectus update (post-effective amendment)
4:07pm
as directors at an annual or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally must … by the stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending
POSASR
ORIC
ORIC Pharmaceuticals Inc
21 Mar 22
Automatic shelf registration (post-effective amendment)
4:02pm
as directors at an annual or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally … by the stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending
424B5
ORIC
ORIC Pharmaceuticals Inc
6 May 21
Prospectus supplement for primary offering
5:01pm
or special meeting of stockholders must provide timely notice thereof in writing. To be timely, a stockholder’s notice generally must be delivered … must be effected at a duly called annual or special meeting of stockholders and may not be effected by written consent.
Amending our certificate
S-3ASR
0w3zdgbtg lg
6 May 21
Automatic shelf registration
4:33pm
424B4
sq1940hnj9r55baqz
13 Nov 20
Prospectus supplement with pricing info
5:21pm
DRS
spvsjogprwvpr 8g
20 Jul 20
Draft registration statement
12:00am
8-K
EX-3.2
9w2iywszh d2et
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
8-K
EX-3.1
4ovumlx
28 Apr 20
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:22pm
424B4
0bm wzxsbw2
24 Apr 20
Prospectus supplement with pricing info
5:04pm
S-1/A
lbiekj 3kitn
20 Apr 20
IPO registration (amended)
6:17am
S-1/A
EX-3.4
19xy2kn5dn5bwtnc
20 Apr 20
IPO registration (amended)
6:17am
S-1
pkiuc 2ppjt7gt2wkng3
28 Feb 20
IPO registration
5:32pm
S-1
EX-3.2
8qde3i
28 Feb 20
IPO registration
5:32pm
S-1
EX-3.3
6f7djnpv13jo7 0s0u
28 Feb 20
IPO registration
5:32pm
S-1
EX-3.4
mi8dhi64
28 Feb 20
IPO registration
5:32pm
DRS/A
zmldai c6ugs
24 Jan 20
Draft registration statement (amended)
12:00am
DRS
zz517
13 Dec 19
Draft registration statement
12:00am